Share the post "Promoter(Buy/Sell) : Inox Wind and Lotus Eye Hospital and Institute on 08 Jul 2024"
| Company | Promoter | Buy/Sell | Qty Traded | Price | Mode | Dates | Traded(%) | Before Per(%) | After Per(%) | Price Change |
|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Eye Hospital and Institute Limited | S Rajkumar | Sell | 130K | 57.19 | Market Sale | 26/06/24 To 06/07/24 | -0.62 | 0.83 | 0.21 | – |
| Inox Wind Limited | Inox Wind Energy Limited | Buy | 200M | 10 | Others | 03/07/24 To 05/07/24 | +99.99 | very low | 99.99 | +9.63 |
| Inox Wind Limited | Inox Wind Energy Limited | Buy | 500M | 10 | Others | 28/06/24 To 29/06/24 | +99.99 | very low | 99.99 | – |
Today’s major promoter deals are listed below where the clients Inox Wind Energy Limited And S Rajkumar played a major role. Let’s uncover them to stay abreast of the latest dynamics in the trading world.Lotus Eye Hospital and Institute Limited company’s 130K of shares have been sold by promoter S Rajkumar at a price of ₹57.19 per share in between 26-Jun-2024 to 06-Jul-2024. Initially, their total percentage of shares was 0.83%. After selling -0.62% of shares, their total percentage of shares amounted to 0.21%.
Inox Wind Limited company’s 200M of shares have been purchased by promoter Inox Wind Energy Limited at a price of ₹10 per share from offline market in between 03-Jul-2024 to 05-Jul-2024. Initially, their total percentage of shares was 0%. After purchasing an additional 99.99% of shares, their total percentage of shares amounted to 99.99%. The positive price fluctuation shows that the price of the asset has increased by 9.63 from 05/07/24 to the present date.
Inox Wind Limited company’s 500M of shares have been purchased by promoter Inox Wind Energy Limited at a price of ₹10 per share from offline market in between 28-Jun-2024 to 29-Jun-2024. Initially, their total percentage of shares was 0%. After purchasing an additional +99.99% of shares, their total percentage of shares amounted to 99.99%.
Lotus Eye Hospital and Institute Limited
128.91
Net Sales
6.23
Net Profit
131.97
Total Income
123.40
Expenditure
71.0
Current Price
148
Market Cap
For Lotus Eye Hospital and Institute Limited, the latest financial data showcases impressive results. The company reported net sales of ₹128.91 million and total income of ₹131.97 million for the quarter. Expenditure was ₹123.40 million, resulting in a net profit of ₹6.23 million. EPS for continuing operations was ₹0.30. Additional financial details include other income of ₹3.06 million, finance costs of ₹0.57 million, and employee benefit expenses of ₹28.08 million. Depreciation and amortization expenses were ₹10.57 million. Current tax was ₹2.36 million and deferred tax amounted to ₹-0.03 million. Total comprehensive income for the period was ₹6.09 million, with other comprehensive income net of taxes at ₹-0.14 million.
The company has a market capitalization of ₹148 crore and a current stock price of ₹71.0. Historically, the stock has fluctuated between ₹111 / 44.1. With a Price-to-Earnings (P/E) ratio of 50.7, the stock appears highly valued. The book value per share is ₹28.6, and the dividend yield is 0.69%. The Return on Capital Employed (ROCE) is 6.97% and the Return on Equity (ROE) is 4.97%. The debt-to-equity ratio is very low at 0.00, although the company reports a net cash flow of ₹-2.35 crore. The Piotroski score is 5.00, and the Graham Number estimates the intrinsic value of the stock at ₹30.0. The Price-to-Book (P/B) ratio is 2.48, indicating the stock is trading at a premium relative to its book value.
Inox Wind Limited
6,072.90
Net Sales
701.90
Net Profit
6,286.90
Total Income
5,585.00
Expenditure
226
Current Price
29,450
Market Cap
In Inox Wind Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹6,072.90 million, with total income of ₹6,286.90 million. The expenditure was ₹5,585.00 million, leading to a net profit of ₹701.90 million. Earnings per Share (EPS) for continuing operations were reported at ₹2.15. The financial overview also includes other income of ₹214.00 million, finance costs of ₹378.60 million, and employee benefit expenses totaling ₹198.20 million. Depreciation and amortization expenses were ₹118.00 million. Current and deferred taxes were recorded at ₹0.00 million and ₹0.00 million, respectively. The total comprehensive income for the period was ₹701.60 million, and other comprehensive income net of taxes was ₹-0.30 million.
With a market capitalization of ₹29,450 crore, the company’s stock is currently priced at ₹226. The historical trading range of the stock is ₹237 / 47.0. The P/E ratio is remarkably high at 395, suggesting a significant valuation. The book value stands at ₹13.0, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 4.25%, and the Return on Equity (ROE) is -1.71%. The debt-to-equity ratio is very low at 1.91, though the company shows a negative net cash flow of ₹-9.45 crore. The Piotroski score is 4.00, with the Graham Number pegged at ₹13.0. The Price-to-Book (P/B) ratio of 17.4 highlights a premium valuation.
